| Literature DB >> 22113433 |
Ellen M B P Reuling1, Inger N Sierevelt, Michel P J van den Bekerom, Elsa F Hilverdink, J Marco Schnater, C Niek van Dijk, J Carel Goslings, Ernst L F B Raaymakers.
Abstract
INTRODUCTION: To study the association between potential prognostic factors and functional outcome at 1 and 5 year follow-up in patients with femoral neck fractures treated with an arthroplasty. To analyze the reliability of the Harris hip score (HHS).Entities:
Mesh:
Year: 2011 PMID: 22113433 PMCID: PMC3261383 DOI: 10.1007/s00402-011-1424-0
Source DB: PubMed Journal: Arch Orthop Trauma Surg ISSN: 0936-8051 Impact factor: 3.067
Baseline data from patients with a femoral neck fracture treated with an arthroplasty at trauma and who where eligible to complete the HHS after 1 and 5 years
| Original population( | 1 year post-operatively ( | 5 years post-operatively ( | |
|---|---|---|---|
| Age | |||
| Age at trauma (yr), mean (SD) | 81.1 (6.3) | 80.8 (5.2) | 79.5 (5.8) |
| Gender | |||
| Male | 47 (19%) | 28 (19%) | 14 (12%) |
| Female | 205 (81%) | 120 (81%) | 106 (88%) |
| Side of fracture | |||
| Left | 152 (60%) | 90 (61%) | 69 (42.5%) |
| Right | 100 (40%) | 58 (39%) | 51 (47.5%) |
| Co-morbidity | |||
| Cardiovascular | 72 (28%) | 42 (28%) | 28 (23%) |
| Respiratory | 34 (14%) | 20 (14%) | 14 (12%) |
| Neurological | 59 (23%) | 32 (22%) | 23 (19%) |
| Musculosketal | 53 (21%) | 28 (19%) | 20 (17%) |
| Malignancy | 17 (7%) | 9 (6%) | 6 (5%) |
| Endocrine | 29 (12%) | 20 (14%) | 13 (11%) |
| Number of co-morbidities | |||
| No co-morbidities | 82 (32%) | 53 (36%) | 47 (39%) |
| 1 co-morbidity | 92 (37%) | 49 (33%) | 47 (39%) |
| 2 co-morbidities | 62 (25%) | 36 (24%) | 21 (18%) |
| ≥3 co-morbidities | 16 (6%) | 10 (7%) | 5 (4%) |
| ASA-classification | |||
| ASA 1 | 30 (12%) | 21 (14%) | 24 (20%) |
| ASA 2 | 125 (51%) | 67 (46%) | 68 (56%) |
| ASA 3 | 77 (31%) | 48 (33%) | 26 (22%) |
| ASA 4 | 15 (6%) | 11 (7%) | 2 (2%) |
| ASA 5 | 0 (0%) | 0 (0%) | 0 (0%) |
ASA American Society of Anesthesiologists
Peri-and postoperative results of 252 patients with a femoral neck fracture treated with an arthroplasty
| Prognostic factors | Number of patients (%) |
|---|---|
| Interval between trauma and operation ( | |
| <48 h | 225 (89) |
| >48 h | 27 (11) |
| Surgeon ( | |
| Attending surgeon | 78 (39) |
| Resident | 120 (61) |
| Therapy ( | |
| Hemiarthroplasty | 137 (54) |
| Total hip replacement | 115 (46) |
| Blood loss ( | |
| <500 ml | 181 (85) |
| >500 ml | 33 (15) |
| Peri-operative in-hospital complications associated with the arthroplasty ( | |
| Poor positioning of the prosthesis | 6 (2.2) |
| Broken stem | 1 (0.4) |
| Peri-prosthetic fracture | 2 (0.8) |
| Local post-operative in-hospital complications associated with the arthroplasty ( | |
| Discharging wound | 2 (0.8) |
| Dislocation | 5 (2.0) |
| Superficial wound infection | 3 (1.2) |
| Deep wound infection | 2 (0.8) |
| Hematoma | 19 (7.8) |
| Paresis of gluteul muscle | 1 (0.4) |
| General post-operative in-hospital complications ( | |
| Transient ischemic attack | 3 (1.2) |
| Cerebral vascular accident | 2 (0.8) |
| Delirium | 16 (6.3) |
| Cardial | 22 (8.7) |
| Pulmonary embolism | 2 (0.8) |
| Pneumonia | 3 (1.2) |
| Urinary tract infection | 7 (2.8) |
| Urinary retention | 5 (2.0) |
| Neurological | 4 (1.6) |
| Gastro-intestinal | 4 (1.6) |
| Others | 13 (5.2) |
| Admission duration | |
| Duration in days (SD) | 17.2 (12) |
| Mortality ( | |
| 1 year | 34 (14) |
| 5 years | 121 (48) |
Results (p values) of functional outcome for different predictive factors in univariate and multivariate analyses
| Aspect | Univariate analyses | Multivariate analyses | Univariate analyses | Multivariate analyses | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| HHS1 pain and function | HHS5 pain and function | HHS1 pain and function | HHS5 pain and function | HHS1 pain | HHS5 pain | HHS1 function | HHS5 function | HHS1 pain | HHS5 pain | HHS1 function | HHS5 function | |
| Age (≤80 years/>80 years) |
| 0.67 | NS | –b |
|
|
|
| –b |
|
|
|
| ASA-classification | 0.27 | 0.96 | –b | –b | 0.16 | 0.10 |
| 0.85 | –b | –b | –b | –b |
| Type of arthroplasty | 0.40 | 0.27 | –b | –b |
| 0.40 | 0.96 | 0.32 | –b | –b | –b | –b |
| Delay in surgery (≤48 h/>48 h) | 0.12 | 0.51 | –b | –b | 0.73 | 0.56 |
| 0.71 | –b | –b | NS | –b |
| Surgeon (resident vs attending surgeon) | 0.98 | 0.28 | –b | –b | 0.79 | 0.45 | 0.96 | 0.56 | –b | –b | –b | –b |
| Blood loss (≤500 ml/>500 ml) | 0.68 | 0.69 | –b | –b | 0.56 | 0.55 | 0.95 | 0.99 | –b | –b | –b | –b |
| Local peri-operative in-hospital complications associated with the arthroplasty | –a | –a | –a | –a | –a | –a | –a | –a | –a | –a | –a | –a |
| Local post-operative in-hospital complications | 0.71 | 0.77 | –b | –b | 0.54 | 0.36 | 0.20 | –b | –b | –b | –b | –b |
| General post-operative in-hospital complications |
| 0.92 | NS | –b | 0.42 | 0.52 |
| –b | –b | –b | NS | –b |
| Pre-operative co-morbidity |
|
|
| –b | 0.57 |
|
| –b | –b |
|
|
|
Significant p values are presented in bold
NS not significant in multivariate analysis
aNumbers too small for analysis
bNot entered in multivariate analyses
Fig. 1Functional outcome; mean (SD) modified Harris hip scores with and without co-morbidities after 1 (HHS1) and 5 (HHS5) year post-operative. HHS1 without co-morbidities: 80.6 (15.7), HHS1 with co-morbidities: 71.8 (14.6). HHS5 without co-morbidities: 73.1 (17.4), HHS5 with co-morbidities: 73.2 (13.4). * p = <0.01